Using Virtual Tumour and other industry standard technologies to predict the effects of cancer treatment regimes for the biopharma industry

Physiomics combines systems biology with cutting-edge mathematics to develop models that streamline the drug discovery and development process. They also have extensive experience in traditional PK/ PD analysis and modelling in cancer drug development.

Physiomics provide services as part of our Virtual R&D offering.

You can find out more about Physiomics on their website.